Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: June 2011
-
"Biotech/Pharma Top 50 (plus 6)" By Donald Zuhn — The Intellectual Property Owners Association (IPO) released its 28th annual list of the top 300 organizations receiving U.S. patents. Patent Docs Readers may recall that the U.S. Patent and Trademark Office stopped releasing its annual list of top patent recipients in 2006 in order to "discourag[e]…
-
By Sherri Oslick — On Tuesday morning, attendees at the BIO International Convention had the opportunity to attend a session entitled "The Myriad Case and the Patentability of Isolated DNA Molecules," presented by the team from Wilmer Hale that submitted a joint amicus curiae brief to the Federal Circuit on behalf of BIO and the…
-
By Kwame Mensah — Earlier this month, Antisense Pharma, GmbH, a biopharmaceutical company located in Regensburg, Germany, announced the issuance of U.S. Patent No. 7,963,956, entitled "Portable equipment for administration of fluids into tissues and tumors by convection enhanced delivery technique," which is directed to Convection Enhanced Delivery (CED). CED is being touted as an…
-
By James DeGiulio — One of the highlights of the afternoon sessions at the BIO International Convention was a seminar appropriately entitled "A Brave New World: Patent Litigation Tactics and Strategies for Biosimilars," where an experienced panel of patent attorneys presented their interpretation of the new biosimilars pathway of the Biologics Price Competition and Innovation…
-
The Biotechnology Industry Organization (BIO) is holding its annual BIO International Convention this week in Washington, DC. Founded in 1993, BIO is a nonprofit association seeking supportive biotechnology policies on behalf of more than 1,100 biotechnology companies, state and international affiliates, and related organizations, as well as providing business development services for many emerging biotech…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Novozymes A/S et al. v. Central Trading Enterprises, Inc.1:11-cv-04276; filed June 23, 2011 in the Northern District of Illinois • Plaintiffs: Novozymes A/S; Novozymes North America, Inc.• Defendant: Central Trading Enterprises, Inc. Infringement of U.S.…
-
June 27-30, 2011 – BIO International Convention (Biotechnology Industry Organization) – Washington, DC June 29-30, 2011 – Pharmaceutical Portfolio & Product Life Cycle Management (SMi Group) – London, UK July 8, 2011 – Stanford v. Roche: The Impact on Management of University IP (Technology Transfer Tactics) – 1:00 – 2:00 PM (Eastern) July 16-19, 2011…
-
The Intellectual Property Owners Association (IPO) will be holding its 2011 Annual Meeting on September 11-13, 2011 in Los Angeles, CA. Among the presentations being offered at the annual meeting are: • Recent case law developments;• A look at patent landscaping and analysis;• Legal issues surrounding genetic information research and development;• Damages;• Current state of…
-
IBC Legal Conferences will be holding its 11th Annual Intellectual Property Law Summer School 2011 on August 15-19, 2011 in Cambridge, UK. The five-day conference devotes one day each to the IP law basics, patents, transactions and enforcement, trademark and designs, and copyrights. During the patent and transactions and enforcement days, IBC faculty will offer…
-
By Donald Zuhn — The House of Representatives earlier today passed H.R. 1249, the America Invents Act, by a 304-117 vote. All told, 168 Republicans and 136 Democrats voted in favor of the bill and 67 Republicans and 50 Democrats voted against the legislation (ten members did not vote; the final vote results can be…
Patent Docs 